Virtus ETF Advisers’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-809
| Closed | -$66.2K | – | 552 |
|
|
2024
Q4 | $66.2K | Sell |
809
-435
| -35% | -$35.6K | 0.03% | 410 |
|
|
2024
Q3 | $142K | Buy |
1,244
+21
| +2% | +$2.4K | 0.07% | 331 |
|
|
2024
Q2 | $92.3K | Sell |
1,223
-209
| -15% | -$15.8K | 0.05% | 349 |
|
|
2024
Q1 | $97.8K | Sell |
1,432
-96
| -6% | -$6.56K | 0.05% | 369 |
|
|
2023
Q4 | $96K | Sell |
1,528
-355
| -19% | -$22.3K | 0.06% | 376 |
|
|
2023
Q3 | $96K | Sell |
1,883
-192
| -9% | -$9.79K | 0.06% | 337 |
|
|
2023
Q2 | $104K | Sell |
2,075
-136
| -6% | -$6.79K | 0.06% | 364 |
|
|
2023
Q1 | $82.9K | Sell |
2,211
-853
| -28% | -$32K | 0.05% | 381 |
|
|
2022
Q4 | $147K | Sell |
3,064
-2,846
| -48% | -$136K | 0.08% | 351 |
|
|
2022
Q3 | $142K | Buy |
5,910
+45
| +0.8% | +$1.08K | 0.06% | 362 |
|
|
2022
Q2 | $128K | Buy |
+5,865
| New | +$128K | 0.05% | 358 |
|